Ja. Bartlett et al., RECENT BENZODIAZEPINE USE IN DEPRESSED-PATIENTS - A CONFOUND OF PSYCHOIMMUNOLOGICAL STUDIES, Brain, behavior, and immunity, 10(4), 1996, pp. 380-386
Several studies have indicated that benzodiazepines influence immunity
in both animals and humans. As these medications are commonly utilize
d by and for psychiatric patients, investigation of psycho-immunologic
relationships in human psychiatric disorders may be confounded by use
of these medications. Method: We undertook an investigation for possi
ble effects of recent benzodiazepine use on depression-immune relation
ships by comparing 43 patients with current major depressive disorder
(MDD) who used benzodiazepines in the week prior to study to 27 patien
ts with current MDD but no use of benzodiazepines in the past month. B
oth functional and ennumerative measures were investigated. Results: W
e found no differences in absolute numbers of lymphocytes or the lymph
ocyte and NK functional measures. We did find differences between thes
e two groups in the percentage of lymphocytes and of NK cells. Upon fu
rther analysis, controlling for symptom severity, these differences we
re shown to not be independently predicted by benzodiazepine use. Conc
lusion: Immune measures in subjects with current MDD and recent benzod
iazepine use did not differ from those without such recent use. Theref
ore, such recent use is unlikely to confound PNI results. (C) 1996 Aca
demic Press.